GSK Pledges £1 Billion …
In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-i…
New approach to treatme…
Mitochondria produce energy for the cell and require oxygen to do so. As such, they are the most oxygen-demanding…
A Single Brain Scan Can…
Doctors currently use a variety of tests to identify Alzheimer’s disease, including memory and cognitive tests tha…
Third Rock Raises $1Bn …
Third Rock Ventures, a well-known funder of biotech startups, announced the closure of a billion-dollar fund recen…
Sydney Applauds NSW Fin…
The University of Sydney has revealed that the New South Wales (NSW) state will contribute $143.3 million over fou…
Pfizer and BioNTech ann…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolera…
Oral antiviral drug eff…
The findings, published in the journal Science Advances, identify AVG-388 as the lead drug candidate, which effec…
GSK announces £1 billio…
GSK plc (LSE/NYSE: GSK) announced an investment of £1bn over ten years to accelerate research and development (R&D…
Biomarkers found that c…
Currently, the drug most often used to treat glioblastoma, temozolomide, is uniquely able to cross the blood/brai…
COVID-19 rebound after …
In a study published June 20, 2022 in Clinical Infectious Diseases, researchers at University of California San D…
Novartis announces Natu…
Novartis announced that Nature Medicine published final results from both the two- and three-copy cohorts of the c…
Novel drug combo activa…
"Long-term effective treatments are difficult to achieve in melanoma patients due to a variety of factors, one of…
